Clearance Summary
IS-III active Short Implant received FDA 510(k) clearance under submission number K232049, sponsored by Neobiotech Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2024-03-28.
- Submission: K232049
- Applicant / Sponsor: Neobiotech Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Dental
- Device class: Class II
- Regulation citation: 21 CFR 872.3640
- Decision date: 2024-03-28
Classification & Regulation
This clearance is catalogued under FDA product code DZE and 21 CFR 872.3640, within the Dental review panel as a Class II device.